BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30468482)

  • 1. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
    Wang Y; Li Y; Song HQ; Sun GW
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia.
    Li J; Sun CK
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3342-3347. PubMed ID: 29917184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
    Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR-744-3p/YY1 signalling.
    Dong X; Xu X; Guan Y
    Cell Biochem Funct; 2020 Oct; 38(7):955-964. PubMed ID: 32157707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non‑coding RNA LINC00460 serves as a potential biomarker and oncogene via regulation of the miR‑320b/PBX3 axis in acute myeloid leukemia.
    Zhuang Q; Jin Z; Zheng X; Jin T; Xiang L
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
    Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
    Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia.
    Sheng H; Zhang J; Ma Y; Zhang Y; Dai Y; Jiang R
    J Gene Med; 2021 Mar; 23(3):e3317. PubMed ID: 33474753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
    Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
    BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
    Hong Z; Zhang R; Qi H
    Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
    Zhang P; Sun D; Sun X; Li H
    Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
    Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
    Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
    Fang Z; Wang X; Wu J; Xiao R; Liu J
    Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
    Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
    J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
    Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
    Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
    EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
    Tan Z; Zhu K; Yin Y; Luo Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma.
    Wen JJ; Ma YD; Yang GS; Wang GM
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):498-503. PubMed ID: 28239821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.